Search company, investor...
Search
GT Medical Technologies company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

gtmedtech.com

Founded Year

2017

Stage

Series B | Alive

Total Raised

$28.45M

Last Raised

$16M | 2 yrs ago

About GT Medical Technologies

GT Medical Technologies focuses on improving the lives of patients with brain tumors. The company created the GammaTile, a device that has shown to be effective in treating tumors that recurred after conventional therapy.

GT Medical Technologies Headquarters Location

1809 S. Holbrook Lane Suite 107

Tempe, Arizona, 85281,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing GT Medical Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GT Medical Technologies is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,575 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health IT

7,901 items

GT Medical Technologies Patents

GT Medical Technologies has filed 10 patents.

The 3 most popular patent topics include:

  • Radiation therapy
  • Medical physics
  • Radiobiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/11/2019

8/16/2022

Radiation therapy, Medical physics, Radiobiology, Radiation protection, Radiation health effects

Grant

Application Date

7/11/2019

Grant Date

8/16/2022

Title

Related Topics

Radiation therapy, Medical physics, Radiobiology, Radiation protection, Radiation health effects

Status

Grant

Latest GT Medical Technologies News

06:00 EDT GT Medical Technologies Chief Technology Officer Honored by Mensa With the Copper Black Award for Creative Achievement

Jul 12, 2022

News provided by Share this article Share this article TEMPE, Ariz., July 12, 2022 /PRNewswire/ -- For his invention of GammaTile® Therapy used to treat operable brain tumors, David Brachman, M.D. is the 2022 winner of the Mensa Foundation's Copper Black Award for Creative Achievement. is the 2022 winner of the Mensa Foundation's Copper Black Award for Creative Achievement. "It's always great to see how Mensa members apply their intelligence and creativity toward practical solutions for real problems. Brain cancer is obviously a significant problem, and we were impressed by Dr. Brachman's novel approach to it," said Charlie Steinhice, president of the Mensa Foundation. "GammaTile adds value to an existing surgical procedure by delivering radiation directly into the tumor cavity, so it starts more quickly and delivers the radiation where it's needed the most. This aligns perfectly with the Mensa Foundation's mission: Unleashing intelligence for the benefit of humanity." The innovative design of GammaTile Therapy delivers the radiation source directly to the tumor cells while helping to protect the surrounding healthy brain tissue. GammaTile Therapy is helping to improve the lives of patients with all types of brain tumors including high-grade gliomas, brain metastases, and malignant meningiomas. There have been relatively few advances in the treatment of brain tumors in the last 40 years. In fact, GammaTile Therapy is the only treatment for glioblastoma, the most aggressive form of brain cancer, to be FDA cleared in the past 10 years. "Receiving this award confirms what I have long suspected, just because one's solution to a problem may seem out of sync with that of most others it does not mean we were the one amiss," said GT Medical Technologies Co-Founder and Chief Technology Officer Dr. David Brachman. "It is also interesting that this award from the Mensa Foundation, an organization concerned with the mind, was given this year for a medical therapy developed to protect the mind from the impact of brain tumors." Dr. Brachman is the inventor of the company's more than 25 granted patents and is a board-certified radiation oncologist. He has authored over 60 peer-reviewed papers and continues to work on advancing the fundamental understanding of brain tumors to help enhance the standard of care. About GT Medical Technologies, Inc. Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies to improve the lives of patients with brain tumors. GammaTile Therapy received FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly diagnosed malignant tumors. The 3D, resorbable collagen tiles embedded with radiation sources are implanted during the last five minutes of brain tumor resection, providing an immediate, dose-intense treatment to eliminate residual tumor cells. This "one and done" procedure allows patients to receive their course of radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy. For more information, visit  www.gtmedtech.com  and follow  @GammaTile  on Twitter and  LinkedIn . About Mensa Foundation For more than 50 years, the Mensa Education and Research Foundation has advocated for intelligence by providing scholarships, promoting research, championing gifted youth, and empowering educators. Governed by a volunteer Board of Trustees, the Mensa Foundation is a 501(c)(3) organization funded by American Mensa, Mensa members, and other charitable donations. Media contact:

GT Medical Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

GT Medical Technologies Rank

  • When was GT Medical Technologies founded?

    GT Medical Technologies was founded in 2017.

  • Where is GT Medical Technologies's headquarters?

    GT Medical Technologies's headquarters is located at 1809 S. Holbrook Lane, Tempe.

  • What is GT Medical Technologies's latest funding round?

    GT Medical Technologies's latest funding round is Series B.

  • How much did GT Medical Technologies raise?

    GT Medical Technologies raised a total of $28.45M.

  • Who are the investors of GT Medical Technologies?

    Investors of GT Medical Technologies include Medical Technology Venture Partners, MVM Partners and Bluestone Venture Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.